Chongqing Zhien Pharmaceutical

Chongqing Zhien Pharmaceutical is a prominent Chinese pharmaceutical company specializing in the research, development, and large-scale manufacturing of active pharmaceutical ingredients (APIs) and finished dosage forms. The company is globally recognized as a leading producer of Orlistat, a key medication for the treatment of obesity and weight management. Its extensive product portfolio also includes anti-infectives, cardiovascular agents, and gastrointestinal drugs, supported by multiple state-of-the-art GMP-certified facilities. Zhien Pharmaceutical operates a robust supply chain, providing high-quality chemical drugs to both domestic and international markets. The company integrates R&D with manufacturing to maintain a competitive edge in the global generic drug industry.